PYRIMIDINES FOR DEGRADING BRUTON'S TYROSINE KINASE

The present invention provides for compounds of formula (I), wherein R1, R2, R3, R4A, R4b, and R5, are as defined herein, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of CLL. La presente invención proporciona compuestos de la Fórmula (I) (ver Fórmula) (I)...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ADAMS Ashley M, BIANNIC Berenger, ZHAO Xianrui, RIVKIN Alexey A, JIA Zhaozhong J, ZABLOCKI Jeffery A, MARIN Violeta L, BURKE Jason P, MORTEZAEI Shahab, OKANO Akinori, BIAN Zhiguo, WOLLER Kevin R, KATCHER Matthew H, MALI Venkat Reddy, PAYETTE Joshua N, SCHOLZ Spencer O, NOEY Elizabeth L, JIANG Xingyu
Format: Patent
Sprache:eng ; spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ADAMS Ashley M
BIANNIC Berenger
ZHAO Xianrui
RIVKIN Alexey A
JIA Zhaozhong J
ZABLOCKI Jeffery A
MARIN Violeta L
BURKE Jason P
MORTEZAEI Shahab
OKANO Akinori
BIAN Zhiguo
WOLLER Kevin R
KATCHER Matthew H
MALI Venkat Reddy
PAYETTE Joshua N
SCHOLZ Spencer O
NOEY Elizabeth L
JIANG Xingyu
description The present invention provides for compounds of formula (I), wherein R1, R2, R3, R4A, R4b, and R5, are as defined herein, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of CLL. La presente invención proporciona compuestos de la Fórmula (I) (ver Fórmula) (I); en donde R1, R2, R3, R4A, R4b, y R5, son como se definen en la presente descripción, y sales farmacéuticamente aceptables de estos, que son útiles como agentes en el tratamiento de la CLL.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MX2024011120A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MX2024011120A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MX2024011120A3</originalsourceid><addsrcrecordid>eNrjZDAKiAzy9PV08fRzDVZw8w9ScHF1D3IEct0VnIJCQ_z91IMVQiKD_IOBChS8Pf0cg115GFjTEnOKU3mhNDeDkptriLOHbmpBfnxqcUFicmpeakm8b4SRgZGJgaGhoZGBozFRigDbMidi</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PYRIMIDINES FOR DEGRADING BRUTON'S TYROSINE KINASE</title><source>esp@cenet</source><creator>ADAMS Ashley M ; BIANNIC Berenger ; ZHAO Xianrui ; RIVKIN Alexey A ; JIA Zhaozhong J ; ZABLOCKI Jeffery A ; MARIN Violeta L ; BURKE Jason P ; MORTEZAEI Shahab ; OKANO Akinori ; BIAN Zhiguo ; WOLLER Kevin R ; KATCHER Matthew H ; MALI Venkat Reddy ; PAYETTE Joshua N ; SCHOLZ Spencer O ; NOEY Elizabeth L ; JIANG Xingyu</creator><creatorcontrib>ADAMS Ashley M ; BIANNIC Berenger ; ZHAO Xianrui ; RIVKIN Alexey A ; JIA Zhaozhong J ; ZABLOCKI Jeffery A ; MARIN Violeta L ; BURKE Jason P ; MORTEZAEI Shahab ; OKANO Akinori ; BIAN Zhiguo ; WOLLER Kevin R ; KATCHER Matthew H ; MALI Venkat Reddy ; PAYETTE Joshua N ; SCHOLZ Spencer O ; NOEY Elizabeth L ; JIANG Xingyu</creatorcontrib><description>The present invention provides for compounds of formula (I), wherein R1, R2, R3, R4A, R4b, and R5, are as defined herein, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of CLL. La presente invención proporciona compuestos de la Fórmula (I) (ver Fórmula) (I); en donde R1, R2, R3, R4A, R4b, y R5, son como se definen en la presente descripción, y sales farmacéuticamente aceptables de estos, que son útiles como agentes en el tratamiento de la CLL.</description><language>eng ; spa</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240918&amp;DB=EPODOC&amp;CC=MX&amp;NR=2024011120A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240918&amp;DB=EPODOC&amp;CC=MX&amp;NR=2024011120A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ADAMS Ashley M</creatorcontrib><creatorcontrib>BIANNIC Berenger</creatorcontrib><creatorcontrib>ZHAO Xianrui</creatorcontrib><creatorcontrib>RIVKIN Alexey A</creatorcontrib><creatorcontrib>JIA Zhaozhong J</creatorcontrib><creatorcontrib>ZABLOCKI Jeffery A</creatorcontrib><creatorcontrib>MARIN Violeta L</creatorcontrib><creatorcontrib>BURKE Jason P</creatorcontrib><creatorcontrib>MORTEZAEI Shahab</creatorcontrib><creatorcontrib>OKANO Akinori</creatorcontrib><creatorcontrib>BIAN Zhiguo</creatorcontrib><creatorcontrib>WOLLER Kevin R</creatorcontrib><creatorcontrib>KATCHER Matthew H</creatorcontrib><creatorcontrib>MALI Venkat Reddy</creatorcontrib><creatorcontrib>PAYETTE Joshua N</creatorcontrib><creatorcontrib>SCHOLZ Spencer O</creatorcontrib><creatorcontrib>NOEY Elizabeth L</creatorcontrib><creatorcontrib>JIANG Xingyu</creatorcontrib><title>PYRIMIDINES FOR DEGRADING BRUTON'S TYROSINE KINASE</title><description>The present invention provides for compounds of formula (I), wherein R1, R2, R3, R4A, R4b, and R5, are as defined herein, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of CLL. La presente invención proporciona compuestos de la Fórmula (I) (ver Fórmula) (I); en donde R1, R2, R3, R4A, R4b, y R5, son como se definen en la presente descripción, y sales farmacéuticamente aceptables de estos, que son útiles como agentes en el tratamiento de la CLL.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAKiAzy9PV08fRzDVZw8w9ScHF1D3IEct0VnIJCQ_z91IMVQiKD_IOBChS8Pf0cg115GFjTEnOKU3mhNDeDkptriLOHbmpBfnxqcUFicmpeakm8b4SRgZGJgaGhoZGBozFRigDbMidi</recordid><startdate>20240918</startdate><enddate>20240918</enddate><creator>ADAMS Ashley M</creator><creator>BIANNIC Berenger</creator><creator>ZHAO Xianrui</creator><creator>RIVKIN Alexey A</creator><creator>JIA Zhaozhong J</creator><creator>ZABLOCKI Jeffery A</creator><creator>MARIN Violeta L</creator><creator>BURKE Jason P</creator><creator>MORTEZAEI Shahab</creator><creator>OKANO Akinori</creator><creator>BIAN Zhiguo</creator><creator>WOLLER Kevin R</creator><creator>KATCHER Matthew H</creator><creator>MALI Venkat Reddy</creator><creator>PAYETTE Joshua N</creator><creator>SCHOLZ Spencer O</creator><creator>NOEY Elizabeth L</creator><creator>JIANG Xingyu</creator><scope>EVB</scope></search><sort><creationdate>20240918</creationdate><title>PYRIMIDINES FOR DEGRADING BRUTON'S TYROSINE KINASE</title><author>ADAMS Ashley M ; BIANNIC Berenger ; ZHAO Xianrui ; RIVKIN Alexey A ; JIA Zhaozhong J ; ZABLOCKI Jeffery A ; MARIN Violeta L ; BURKE Jason P ; MORTEZAEI Shahab ; OKANO Akinori ; BIAN Zhiguo ; WOLLER Kevin R ; KATCHER Matthew H ; MALI Venkat Reddy ; PAYETTE Joshua N ; SCHOLZ Spencer O ; NOEY Elizabeth L ; JIANG Xingyu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MX2024011120A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ADAMS Ashley M</creatorcontrib><creatorcontrib>BIANNIC Berenger</creatorcontrib><creatorcontrib>ZHAO Xianrui</creatorcontrib><creatorcontrib>RIVKIN Alexey A</creatorcontrib><creatorcontrib>JIA Zhaozhong J</creatorcontrib><creatorcontrib>ZABLOCKI Jeffery A</creatorcontrib><creatorcontrib>MARIN Violeta L</creatorcontrib><creatorcontrib>BURKE Jason P</creatorcontrib><creatorcontrib>MORTEZAEI Shahab</creatorcontrib><creatorcontrib>OKANO Akinori</creatorcontrib><creatorcontrib>BIAN Zhiguo</creatorcontrib><creatorcontrib>WOLLER Kevin R</creatorcontrib><creatorcontrib>KATCHER Matthew H</creatorcontrib><creatorcontrib>MALI Venkat Reddy</creatorcontrib><creatorcontrib>PAYETTE Joshua N</creatorcontrib><creatorcontrib>SCHOLZ Spencer O</creatorcontrib><creatorcontrib>NOEY Elizabeth L</creatorcontrib><creatorcontrib>JIANG Xingyu</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ADAMS Ashley M</au><au>BIANNIC Berenger</au><au>ZHAO Xianrui</au><au>RIVKIN Alexey A</au><au>JIA Zhaozhong J</au><au>ZABLOCKI Jeffery A</au><au>MARIN Violeta L</au><au>BURKE Jason P</au><au>MORTEZAEI Shahab</au><au>OKANO Akinori</au><au>BIAN Zhiguo</au><au>WOLLER Kevin R</au><au>KATCHER Matthew H</au><au>MALI Venkat Reddy</au><au>PAYETTE Joshua N</au><au>SCHOLZ Spencer O</au><au>NOEY Elizabeth L</au><au>JIANG Xingyu</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PYRIMIDINES FOR DEGRADING BRUTON'S TYROSINE KINASE</title><date>2024-09-18</date><risdate>2024</risdate><abstract>The present invention provides for compounds of formula (I), wherein R1, R2, R3, R4A, R4b, and R5, are as defined herein, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of CLL. La presente invención proporciona compuestos de la Fórmula (I) (ver Fórmula) (I); en donde R1, R2, R3, R4A, R4b, y R5, son como se definen en la presente descripción, y sales farmacéuticamente aceptables de estos, que son útiles como agentes en el tratamiento de la CLL.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; spa
recordid cdi_epo_espacenet_MX2024011120A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title PYRIMIDINES FOR DEGRADING BRUTON'S TYROSINE KINASE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T23%3A47%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ADAMS%20Ashley%20M&rft.date=2024-09-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMX2024011120A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true